Acid Base Flashcards
The degree of respiratory compensation expected in a metabolic acidosis can be predicted from the relationship
Paco 2 = (1.5 × [HCO 3 − ]) + 8 ± 2 (Winter’s equation).
_______—defined as independently coexisting disorders, not merely compensatory responses—are often seen in patients in critical care units and can lead to dangerous extremes of pH
Mixed acid-base disorders
The “normal” value for the AG reported by clinical laboratories has declined with improved methodology for measuring plasma electrolytes and ranges from _____mmol/L
6−12
Which of the following can cause a decrease in the anion gap?
A. Hyperlipidemia
B. Uremia
C. Lactic acidosis
D. Salicylate intoxication
A
Metabolic acidosis can occur because of an increase in _____production (such as lactate and ketoacids), loss of bicarbonate (as in diarrhea), or accumulation of endogenous acids because of inappropriately low excretion of net acid by the kidney (as in chronic kidney disease).
endogenous acid
The fall in blood pH is accompanied by a characteristic increase in ventilation, especially the tidal volume (______).
Kussmaul respiration
There are two major categories of clinical metabolic acidosis: ______
high-AG and non-AG acidosis
The p ence of metabolic acidosis, a normal AG, and hyperchloremia denotes the presence of a ______
non-AG metabolic acidosis.
Treatment of metabolic acidosis with alkali should be reserved for _____ except when the patient has no “_____ ” in plasma.
severe acidemia
potential HCO 3 −
Metabolizable acid anion
B hydroxybutyrate, acetoacetate, lactate
patients with a non-AG acidosis (_______)
hyperchloremic acidosis
AG acidosis attributable to a nonmetabolizable anion due to advanced kidney failure (______)
“uremic” acidosis
patients with a non-AG acidosis (hyperchloremic acidosis) or an AG acidosis attributable to a nonmetabolizable anion due to advanced kidney failure (“uremic” acidosis) should receive alkali therapy, either PO (NaHCO 3 tablets or Shohl’s solution) or IV (NaHCO 3 ), in an amount necessary to slowly increase the plasma [HCO 3 − ] to a target value of ______
22 mmol/L.
Bicarbonate therapy in diabetic ketoacidosis (DKA) is reserved for adult patients with severe acidemia _____) and/or evidence of shock.
(pH <7.00
In DKA with severe acidemia bicarbonate therapy:
IV, as a slow infusion of 50 meq of NaHCO3 diluted in 300 mL of a saline solution, over 30–45 min, during the initial 1–2 h of therapy.
A reasonable initial goal in DKA is to increase the [HCO3 − ] to 1____and the pH to approximately _____, but clearly not to increase these values to normal.
0–12 mmol/L
7.20
There are four principal causes of a high-AG acidosis: ______
(1) lactic acidosis
(2) ketoacidosis
(3) ingested toxins
(4) acute and chronic kidney failure
Pyroglutamic acidemia may occur in critically ill patients receiving _____, which causes depletion of glutathione and accumulation of 5-oxyprolene.
acetaminophen
______, which may be associated with jejunoileal bypass, short bowel syndrome, or intestinal obstruction, is due to formation of d-lactate by gut bacteria.
d-Lactic acid acidosis
Alkali therapy is generally advocated for acute, severe acidemia (pH___) to improve cardiovascular function
<7.00
A reasonable approach with severe acidemia is to infuse sufficient NaHCO 3 to raise arterial pH to no more than___ or the [HCO 3 – ] to no more than ____
7.2
12 mmol/L
This condition is caused by increased fatty acid metabolism and the accumulation of ketoacids (acetoacetate and β-hydroxybutyrate).
DKA